Dauntless Investment Group »

Lineage Cell Therapeutics In shares owned by Dauntless Investment Group

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Dauntless Investment Group from 13F filings

Historical chart of Dauntless Investment Group investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Dauntless Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Dauntless Investment Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.7M 1.6M 1.69
2025-06-30 $731k 1.2M 0.61

More positions owned by Dauntless Investment Group

Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Spdr Series Trust S&p Biotech Put Option (XBI)
Apple Put Option (AAPL)
Palantir Technologies Cl A Put Option (PLTR)
Select Sector Spdr Tr Sbi Cons Discr Put Option (XLY)
Meta Platforms Cl A Put Option (META)
Tiziana Life Sciences Common Shares (TLSA)
Coca-Cola Company Put Option (KO)
Okyo Pharma Shs New (OKYO)
Agnico (AEM)
Coreweave Com Cl A Put Option (CRWV)
Marathon Petroleum Corp Call Option (MPC)
Ishares Tr China Lg-cap Etf Call Option (FXI)
NVIDIA Corporation Put Option (NVDA)
Lineage Cell Therapeutics In (LCTX)

View all positions for Dauntless Investment Group

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Group
Raffles Associates
Brian McDonald
Millennium Management
Geode Capital Management
BlackRock
Renaissance Technologies
Dauntless Investment Group
State Street Corporation
Morgan Stanley
GSA Capital Partners
Red Crane Wealth Management
Northern Trust
Eudaimonia Asset Management

View all funds holding Lineage Cell Therapeutics In